4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-032865
Chairman and CEO bought 12,800 shares at an average $1.22 ($15,659)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-05-12 | Purchase | +8,000 | $1.10 | $8,800 | 10,722,746 | D |
| Niihara Yutaka Chairman and CEO | 2021-05-13 | Purchase | +3,500 | $1.41 | $4,935 | 10,726,246 | D |
| Niihara Yutaka Chairman and CEO | 2021-05-14 | Purchase | +1,300 | $1.48 | $1,924 | 10,727,546 | D |
| Open-market purchases · 12,800 sh · avg $1.22 · $15,659 | |||||||
Loading xslF345X03/doc4.xml…